Table 5.
Complications and short-term morbidities of GBS EOS episodes based on type of prenatal antibiotic received for full term neonates with GBS positive mothers.
| First-line antibiotics (n = 51) |
Second-line antibiotics (n = 42) |
No antibiotics (n = 122) |
p-value | |
|---|---|---|---|---|
| Mortality | 1 (2.0) | 1 (2.4) | 6 (4.9) | .70 |
| Tracheostomy at discharge | 0 (0.0) | 0 (0.0) | 0 (0.0) | - |
| Supplemental oxygen at discharge | 3 (5.9) | 0 (0.0) | 0 (0.0) | .02 |
| Ventriculitis | 0 (0.0) | 0 (0.0) | 0 (0.0) | - |
| Septic Arthritis | 0 (0.0) | 0 (0.0) | 0 (0.0) | - |
| Cellulitis | 0 (0.0) | 0 (0.0) | 1 (0.8) | 1 |
| Hydrocephalus | 0 (0.0) | 0 (0.0) | 0 (0) | - |
| Failed hearing | 3 (5.9) | 0 (0.0) | 2 (1.6) | .16 |
Data are presented as n (%) unless otherwise specified.
GBS, Group B Streptococcus; EOS, Early-Onset Sepsis.
Fisher’s exact test was used to compare for difference across groups by type of antibiotic received for each variable. p-values could not be calculated due to too few observations.